O=C1C[C@@H]2[C@@H](c3ccccc3)[C@@H]3C(=O)c4ccccc4NC(=O)[C@H]3[C@]2(O)c2ccccc2N1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?